Home health products supplier Invacare (NYSE:IVC) is still enmeshed in negotiations with the U.S. Food and Drug Administration over a possible shutdown of some wheelchair production at an Elyria, Ohio plant. In December, Invacare announced that the FDA had asked it to enter into a legal agreement that would require the company to suspend “certain” […]
Pharmaceuticals distributor and medical products supplier Cardinal Health (NYSE:CAH) plans to make $90 million in acquisitions this year to boost its business in China. Dublin, Ohio-based Cardinal entered the Chinese market with the $470 million acquisition in 2010 of Chinese drug distributor Yong Yu. Now, Cardinal is looking to make further acquisitions in the country […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Despite its troubles related to the Riata and the Riata ST lead recalls, St. Jude Medical CEO Daniel Starks told analysts Wednesday that the company will gain a 1 percentage point market share in the global cardiac rhythm market in 2012. The company’s CRM segment includes implantable cardioverter defibrillator and pacemaker products. In discussing the […]
Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is currently in clinical trials, according to a statement from Meridian announcing the Cincinnati-area company’s first-quarter earnings. Meridian plans to launch three to four new illumigene tests per […]
Meridian Bioscience (NASDAQ:VIVO) plans to launch up to four new tests from its illumigene molecular diagnostic testing platform over the next year. Cincinnati-area Meridian is betting big on the illumigene platform, which it says provides its hospital and laboratory customers with a simpler, cheaper option to test samples for certain types of bacteria without the […]
Sterilization products maker STERIS (NYSE:STE) is experiencing a more slow and costly transition to a new version of its flagship sterilization system than the company expected. The company had earlier projected between 5,000 and 8,000 sales on the year of its new System 1E, a liquid chemical sterilizing system used by hospitals, surgical centers and […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Pharmaceuticals distributor Cardinal Health (NYSE:CAH) reported increased, adjusted first-quarter earnings, but investors showed only modest enthusiasm as the company’s full-year outlook remained the same. Cardinal reported adjusted earnings from continuing operations of $256 million, or 73 cents per diluted share, compared with $231 million or 66 cents per diluted share a year earlier, according to […]
SurModics (NASDAQ:SRDX), a drug delivery and surface modification company, announced this week that it was cutting 9 percent of its workforce, which included the departure of its CFO, and closing a plant. It’s a major restructuring on the heels of another big cost-cutting move less than a year ago where it cut 13 percent of […]
In his debut earnings call with analysts Tuesday, Medtronic (NYSE:MDT) CEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company whose operating results for the first fiscal quarter he described as “unsatisfactory.” Profits in the first fiscal quarter ended July 29 fell to $821 million […]
Stem cell therapy developer Athersys (NASDAQ:ATHX) plans to begin phase 2 clinical trials of its MultiStem therapy for stroke and heart attack patients by the end of the year. Moving ahead with its stroke therapy is key for Athersys because that application represents its biggest market. CEO Gil Van Bokkelen pegged the potential stroke market […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Drug distributor Cardinal Health (NYSE: CAH) reported a 19 percent fourth-quarter increase in sales of generic drugs, an area that continues to be a strength for the company. Generics — as well as acquisitions that have allowed the company to sell more generics — contributed to a 9 percent increase in fourth-quarter revenue to $26.8 […]
Cardiology medical device maker AtriCure (NASDAQ:ATRC) expects to receive U.S. regulatory clearance for a new cryoablation system by the end of next quarter. The company’s cryoICE BOX system would use extreme cold to freeze cardiac tissue in order to correct abnormal electrical signals that cause heart arrhythmia. The system was launched during the second quarter […]
The top executive with sterilization products maker STERIS (NYSE:STE) said the transition to a replacement version of its flagship sterilization device is “moving along as expected.” The Mentor, Ohio-based company during the most recent quarter shipped 700 units of its new System 1E device, which is a liquid chemical sterilizing system used by hospitals, surgical […]
Rochester Medical (NASDAQ:ROCM), a Minnesota urology and urinary incontinence treatment company, has a three-year plan to double sales. As such, the company, which makes silicone disposable urological catheters, has been rapidly adding to its U.S. sales force. In a conference call to discuss quarterly performance Thursday, CEO Anthony Conway pointed out that the company has […]
Home health products maker Invacare (NYSE: IVC) reported that a controversial new Medicare competitive bidding program for durable medical equipment has had “no significant impact” on its business. The Elyria, Ohio-based company said it expects the program to be “neutral” to its 2011 earnings, according to a statement announcing its second-quarter financial performance. The first […]